141 related articles for article (PubMed ID: 20842031)
21. Radioiodinated Small-Molecule Tyrosine Kinase Inhibitor for HER2-Selective SPECT Imaging.
Tang L; Peng C; Tang B; Li Z; Wang X; Li J; Gao F; Huang L; Xu D; Zhang P; Zhuang R; Su X; Chen X; Zhang X
J Nucl Med; 2018 Sep; 59(9):1386-1391. PubMed ID: 29653973
[TBL] [Abstract][Full Text] [Related]
22. Receptor Occupancy Imaging Studies in Oncology Drug Development.
Burvenich IJG; Parakh S; Parslow AC; Lee ST; Gan HK; Scott AM
AAPS J; 2018 Mar; 20(2):43. PubMed ID: 29520671
[TBL] [Abstract][Full Text] [Related]
23. Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy.
Hu Y; Liu C; Muyldermans S
Front Immunol; 2017; 8():1442. PubMed ID: 29163515
[TBL] [Abstract][Full Text] [Related]
24. Activatable interpolymer complex-superparamagnetic iron oxide nanoparticles as magnetic resonance contrast agents sensitive to oxidative stress.
Yoo E; Cheng HA; Nardacci LE; Beaman DJ; Drinnan CT; Lee C; Fishbein KW; Spencer RG; Fisher OZ; Doiron AL
Colloids Surf B Biointerfaces; 2017 Oct; 158():578-588. PubMed ID: 28750340
[TBL] [Abstract][Full Text] [Related]
25. Radioiodination of BODIPY and its application to a nuclear and optical dual functional labeling agent for proteins and peptides.
Ono M; Watanabe H; Ikehata Y; Ding N; Yoshimura M; Sano K; Saji H
Sci Rep; 2017 Jun; 7(1):3337. PubMed ID: 28611426
[TBL] [Abstract][Full Text] [Related]
26. Human Epidermal Growth Factor Receptor 2-Targeted PET/Single- Photon Emission Computed Tomography Imaging of Breast Cancer: Noninvasive Measurement of a Biomarker Integral to Tumor Treatment and Prognosis.
Henry KE; Ulaner GA; Lewis JS
PET Clin; 2017 Jul; 12(3):269-288. PubMed ID: 28576166
[TBL] [Abstract][Full Text] [Related]
27. Nanomaterial-Enabled Cancer Therapy.
Quader S; Kataoka K
Mol Ther; 2017 Jul; 25(7):1501-1513. PubMed ID: 28532763
[TBL] [Abstract][Full Text] [Related]
28. Importance of Drug Pharmacokinetics at the Site of Action.
Rizk ML; Zou L; Savic RM; Dooley KE
Clin Transl Sci; 2017 May; 10(3):133-142. PubMed ID: 28160433
[No Abstract] [Full Text] [Related]
29. Improving systemic breast cancer therapy: time to look beyond the primary tumour?
Vandendriessche E; Van De Putte G; Van Den Broecke R; De Jonge E
Facts Views Vis Obgyn; 2015 Dec; 7(4):251-256. PubMed ID: 27729970
[TBL] [Abstract][Full Text] [Related]
30. Dual-Labeled Near-Infrared/(99m)Tc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells.
Yamaguchi H; Tsuchimochi M; Hayama K; Kawase T; Tsubokawa N
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399687
[TBL] [Abstract][Full Text] [Related]
31. [
Laforest R; Lapi SE; Oyama R; Bose R; Tabchy A; Marquez-Nostra BV; Burkemper J; Wright BD; Frye J; Frye S; Siegel BA; Dehdashti F
Mol Imaging Biol; 2016 Dec; 18(6):952-959. PubMed ID: 27146421
[TBL] [Abstract][Full Text] [Related]
32. Development of Companion Diagnostics.
Mankoff DA; Edmonds CE; Farwell MD; Pryma DA
Semin Nucl Med; 2016 Jan; 46(1):47-56. PubMed ID: 26687857
[TBL] [Abstract][Full Text] [Related]
33. Cancer stratification by molecular imaging.
Weber J; Haberkorn U; Mier W
Int J Mol Sci; 2015 Mar; 16(3):4918-46. PubMed ID: 25749472
[TBL] [Abstract][Full Text] [Related]
34. Gallium-68-labeled anti-HER2 single-chain Fv fragment: development and in vivo monitoring of HER2 expression.
Ueda M; Hisada H; Temma T; Shimizu Y; Kimura H; Ono M; Nakamoto Y; Togashi K; Saji H
Mol Imaging Biol; 2015 Feb; 17(1):102-10. PubMed ID: 25049073
[TBL] [Abstract][Full Text] [Related]
35. Polylactide-based paclitaxel-loaded nanoparticles fabricated by dispersion polymerization: characterization, evaluation in cancer cell lines, and preliminary biodistribution studies.
Adesina SK; Holly A; Kramer-Marek G; Capala J; Akala EO
J Pharm Sci; 2014 Aug; 103(8):2546-55. PubMed ID: 24961596
[TBL] [Abstract][Full Text] [Related]
36. Positron emission tomography image-guided drug delivery: current status and future perspectives.
Chakravarty R; Hong H; Cai W
Mol Pharm; 2014 Nov; 11(11):3777-97. PubMed ID: 24865108
[TBL] [Abstract][Full Text] [Related]
37. Design and applications of bispecific heterodimers: molecular imaging and beyond.
Luo H; Hong H; Yang SP; Cai W
Mol Pharm; 2014 Jun; 11(6):1750-61. PubMed ID: 24738564
[TBL] [Abstract][Full Text] [Related]
38. Nanobody: the "magic bullet" for molecular imaging?
Chakravarty R; Goel S; Cai W
Theranostics; 2014; 4(4):386-98. PubMed ID: 24578722
[TBL] [Abstract][Full Text] [Related]
39. 89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors.
Chang AJ; Desilva R; Jain S; Lears K; Rogers B; Lapi S
Pharmaceuticals (Basel); 2012 Jan; 5(1):79-93. PubMed ID: 24288044
[TBL] [Abstract][Full Text] [Related]
40. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.
Eccles SA; Aboagye EO; Ali S; Anderson AS; Armes J; Berditchevski F; Blaydes JP; Brennan K; Brown NJ; Bryant HE; Bundred NJ; Burchell JM; Campbell AM; Carroll JS; Clarke RB; Coles CE; Cook GJ; Cox A; Curtin NJ; Dekker LV; Silva Idos S; Duffy SW; Easton DF; Eccles DM; Edwards DR; Edwards J; Evans D; Fenlon DF; Flanagan JM; Foster C; Gallagher WM; Garcia-Closas M; Gee JM; Gescher AJ; Goh V; Groves AM; Harvey AJ; Harvie M; Hennessy BT; Hiscox S; Holen I; Howell SJ; Howell A; Hubbard G; Hulbert-Williams N; Hunter MS; Jasani B; Jones LJ; Key TJ; Kirwan CC; Kong A; Kunkler IH; Langdon SP; Leach MO; Mann DJ; Marshall JF; Martin L; Martin SG; Macdougall JE; Miles DW; Miller WR; Morris JR; Moss SM; Mullan P; Natrajan R; O'Connor JP; O'Connor R; Palmieri C; Pharoah PD; Rakha EA; Reed E; Robinson SP; Sahai E; Saxton JM; Schmid P; Smalley MJ; Speirs V; Stein R; Stingl J; Streuli CH; Tutt AN; Velikova G; Walker RA; Watson CJ; Williams KJ; Young LS; Thompson AM
Breast Cancer Res; 2013 Oct; 15(5):R92. PubMed ID: 24286369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
